T-cell Therapy Market Size, Share & Trends Report

T-cell Therapy Market Size, Share & Trends Analysis Report By Modality, By Therapy (CAR T-cell, Tumor-Infiltrating Lymphocytes), By Indication (Hematologic Malignancies, Solid Tumors), By Region, And Segment Forecasts, 2021 - 2028

  • Report ID: GVR-3-68038-685-1
  • Number of Pages: 200
  • Format: Electronic (PDF)
  • Historical Range: 2017 - 2019
  • Industry: Healthcare

Market Segmentation

  • T-cell Therapy Modality Outlook (Revenue, USD Million, 2017 - 2028)
    • Research
    • Commercialized
  • T-cell Therapy Type Outlook (Revenue, USD Million, 2017 - 2028)
    • CAR T-cell Therapy
    • T Cell Receptor (TCR)-based
    • Tumor Infiltrating Lymphocytes (TIL)-based
  • T-cell Therapy Indication Outlook (Revenue, USD Million, 2017 - 2028)
    • Hematologic Malignancies
      • Lymphoma
      • Leukemia
      • Myeloma
    • Solid Tumors
      • Melanoma
      • Brain & Central Nervous System
      • Liver Cancer
      • Others
    • Others
  • T-cell Therapy Regional Outlook (Revenue, USD Million, 2017 - 2028)
    • North America
      • North America T-cell Therapy Market, By Modality Type
        • Research
        • Commercialized
      • North America T-cell Therapy Market, By Therapy Type
        • CAR T-cell Therapy
        • T Cell Receptor (TCR)-based
        • Tumor Infiltrating Lymphocytes (TIL)-based
      • North America T-cell Therapy Market, By Indication
        • Hematologic Malignancies
          • Lymphoma
          • Leukemia
          • Myeloma
        • Solid Tumors
          • Melanoma
          • Brain & Central Nervous System
          • Liver Cancer
          • Others
        • Others
      • U.S.
        • U.S. T-cell Therapy Market, By Modality Type
          • Research
          • Commercialized
        • U.S. T-cell Therapy Market, By Therapy Type
          • CAR T-cell Therapy
          • T Cell Receptor (TCR)-based
          • Tumor Infiltrating Lymphocytes (TIL)-based
        • U.S. T-cell Therapy Market, By Indication
          • Hematologic Malignancies
            • Lymphoma
            • Leukemia
            • Myeloma
          • Solid Tumors
            • Melanoma
            • Brain & Central Nervous System
            • Liver Cancer
            • Others
          • Others
      • Canada
        • Canada T-cell Therapy Market, By Modality Type
          • Research
          • Commercialized
        • Canada T-cell Therapy Market, By Therapy Type
          • CAR T-cell Therapy
          • T Cell Receptor (TCR)-based
          • Tumor Infiltrating Lymphocytes (TIL)-based
        • Canada T-cell Therapy Market, By Indication
          • Hematologic Malignancies
            • Lymphoma
            • Leukemia
            • Myeloma
          • Solid Tumors
            • Melanoma
            • Brain & Central Nervous System
            • Liver Cancer
            • Others
          • Others
    • Europe
      • Europe T-cell Therapy Market, By Modality Type
        • Research
        • Commercialized
      • Europe T-cell Therapy Market, By Therapy Type
        • CAR T-cell Therapy
        • T Cell Receptor (TCR)-based
        • Tumor Infiltrating Lymphocytes (TIL)-based
      • Europe T-cell Therapy Market, By Indication
        • Hematologic Malignancies
          • Lymphoma
          • Leukemia
          • Myeloma
        • Solid Tumors
          • Melanoma
          • Brain & Central Nervous System
          • Liver Cancer
          • Others
        • Others
      • Germany
        • Germany T-cell Therapy Market, By Modality Type
          • Research
          • Commercialized
        • Germany T-cell Therapy Market, By Therapy Type
          • CAR T-cell Therapy
          • T Cell Receptor (TCR)-based
          • Tumor Infiltrating Lymphocytes (TIL)-based
        • Germany T-cell Therapy Market, By Indication
          • Hematologic Malignancies
            • Lymphoma
            • Leukemia
            • Myeloma
          • Solid Tumors
            • Melanoma
            • Brain & Central Nervous System
            • Liver Cancer
            • Others
          • Others
      • U.K.
        • U.K. T-cell Therapy Market, By Modality Type
          • Research
          • Commercialized
        • U.K. T-cell Therapy Market, By Therapy Type
          • CAR T-cell Therapy
          • T Cell Receptor (TCR)-based
          • Tumor Infiltrating Lymphocytes (TIL)-based
        • U.K. T-cell Therapy Market, By Indication
          • Hematologic Malignancies
            • Lymphoma
            • Leukemia
            • Myeloma
          • Solid Tumors
            • Melanoma
            • Brain & Central Nervous System
            • Liver Cancer
            • Others
          • Others
    • Asia Pacific
      • Asia Pacific T-cell Therapy Market, By Modality Type
        • Research
        • Commercialized
      • Asia Pacific T-cell Therapy Market, By Therapy Type
        • CAR T-cell Therapy
        • T Cell Receptor (TCR)-based
        • Tumor Infiltrating Lymphocytes (TIL)-based
      • Asia Pacific T-cell Therapy Market, By Indication
        • Hematologic Malignancies
          • Lymphoma
          • Leukemia
          • Myeloma
        • Solid Tumors
          • Melanoma
          • Brain & Central Nervous System
          • Liver Cancer
          • Others
        • Others
      • Japan
        • Japan T-cell Therapy Market, By Modality Type
          • Research
          • Commercialized
        • Japan T-cell Therapy Market, By Therapy Type
          • CAR T-cell Therapy
          • T Cell Receptor (TCR)-based
          • Tumor Infiltrating Lymphocytes (TIL)-based
        • Japan T-cell Therapy Market, By Indication
          • Hematologic Malignancies
            • Lymphoma
            • Leukemia
            • Myeloma
          • Solid Tumors
            • Melanoma
            • Brain & Central Nervous System
            • Liver Cancer
            • Others
          • Others
      • China
        • China T-cell Therapy Market, By Modality Type
          • Research
          • Commercialized
        • China T-cell Therapy Market, By Therapy Type
          • CAR T-cell Therapy
          • T Cell Receptor (TCR)-based
          • Tumor Infiltrating Lymphocytes (TIL)-based
        • China T-cell Therapy Market, By Indication
          • Hematologic Malignancies
            • Lymphoma
            • Leukemia
            • Myeloma
          • Solid Tumors
            • Melanoma
            • Brain & Central Nervous System
            • Liver Cancer
            • Others
          • Others
    • Latin America
      • Latin America T-cell Therapy Market, By Modality Type
        • Research
        • Commercialized
      • Latin America T-cell Therapy Market, By Therapy Type
        • CAR T-cell Therapy
        • T Cell Receptor (TCR)-based
        • Tumor Infiltrating Lymphocytes (TIL)-based
      • Latin America T-cell Therapy Market, By Indication
        • Hematologic Malignancies
          • Lymphoma
          • Leukemia
          • Myeloma
        • Solid Tumors
          • Melanoma
          • Brain & Central Nervous System
          • Liver Cancer
          • Others
        • Others
      • Brazil
        • Brazil T-cell Therapy Market, By Modality Type
          • Research
          • Commercialized
        • Brazil T-cell Therapy Market, By Therapy Type
          • CAR T-cell Therapy
          • T Cell Receptor (TCR)-based
          • Tumor Infiltrating Lymphocytes (TIL)-based
        • Brazil T-cell Therapy Market, By Indication
          • Hematologic Malignancies
            • Lymphoma
            • Leukemia
            • Myeloma
          • Solid Tumors
            • Melanoma
            • Brain & Central Nervous System
            • Liver Cancer
            • Others
          • Others
    • Middle East and Africa (MEA)
      • Middle East and Africa T-cell Therapy Market, By Modality Type
        • Research
        • Commercialized
      • Middle East and Africa  T-cell Therapy Market, By Therapy Type
        • CAR T-cell Therapy
        • T Cell Receptor (TCR)-based
        • Tumor Infiltrating Lymphocytes (TIL)-based
      • Middle East and Africa T-cell Therapy Market, By Indication
        • Hematologic Malignancies
          • Lymphoma
          • Leukemia
          • Myeloma
        • Solid Tumors
          • Melanoma
          • Brain & Central Nervous System
          • Liver Cancer
          • Others
        • Others
      • South Africa
        • South Africa T-cell Therapy Market, By Modality Type
          • Research
          • Commercialized
        • South Africa T-cell Therapy Market, By Therapy Type
          • CAR T-cell Therapy
          • T Cell Receptor (TCR)-based
          • Tumor Infiltrating Lymphocytes (TIL)-based
        • South Africa T-cell Therapy Market, By Indication
          • Hematologic Malignancies
            • Lymphoma
            • Leukemia
            • Myeloma
          • Solid Tumors
            • Melanoma
            • Brain & Central Nervous System
            • Liver Cancer
            • Others
          • Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2017 to 2028
  • Market estimates and forecast for product segments up to 2028
  • Regional market size and forecast for product segments up to 2028
  • Market estimates and forecast for application segments up to 2028
  • Regional market size and forecast for application segments up to 2028
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon